Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $476.8200 (1.02%) ($468.3100 - $477.5100) on Wed. Aug. 2, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.01% (three month average) | RSI | 38 | Latest Price | $476.8200(1.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.6% a day on average for past five trading days. | Weekly Trend | REGN declines -1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(43%) IVW(42%) IWF(42%) | Factors Impacting REGN price | REGN will decline at least -1.005% in a week (0% probabilities). UUP(-9%) VIXM(-7%) TLT(-6%) TIP(-2%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.005% (StdDev 2.01%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
Resistance Level | $501.62 | 5 Day Moving Average | $491.51(-2.99%) | 10 Day Moving Average | $503.53(-5.3%) | 20 Day Moving Average | $501.62(-4.94%) | To recent high | -9.4% | To recent low | 18.6% | Market Cap | $50.557b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |